The implementation of intensity-modulated radiotherapy in the UK

Clinical Oncology

Volumn 22, Issue 8, 2010, Pages 623-628

  Williams, M V ^a   Cooper, T ^b   Mackay, R ^c   Staffurth, J ^d   Routsis, D ^a   Burnet, N ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INFORMATION; INFORMED CONSENT; INTENSITY MODULATED RADIATION THERAPY; PEER REVIEW; POLICY; PRIORITY JOURNAL; PROSTATE CANCER; TRAINING; UNITED KINGDOM; XEROSTOMIA;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INSERVICE TRAINING; NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77956259866     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.06.015     Document Type: Editorial

References (31)

1. Williams M.V., Drinkwater K.J. Geographical variation in radiotherapy services across the UK in 2007 and the effect of deprivation. Clin Oncol 2009, 21:431-440.
2. Williams M.V., Summer E.T., Drinkwater K.J., Barrett A. Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005. Clin Oncol 2007, 19:273-286.
3. Department of Health Radiotherapy: developing a world class service for England May 2007, Available at:, last accessed 19 January 2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_074575.
4. Department of Health Radiotherapy technical development subgroup May 2007, Available at:, last accessed 7 March 2009. http://www.cancer.nhs.uk/documents/nrag_files/technology%20subgroup%20report%20nov06%20-%20fin.pdf.
5. Department of Health Cancer reform strategy 2007, Department of Health, London, Available at:. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081006.
6. Bentzen S.M., Herren G., Cottier B., et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: ESTRO QUARTS Project. Radiother Oncol 2005, 75:355-365.
7. The Scottish Government Cancer in Scotland: radiotherapy activity planning 2011-15 2005, Scottish Executive, Edinburgh, Available at. http://www.scotland.gov.uk/Publications/2006/01/24131719/0.
8. Welsh Assembly Government Radiotherapy equipment needs and workforce implications 2006-2016. Cancer Services Coordinating Group, Radiotherapy & Chemotherapy Advisory Group Available at:, last accessed 3 April 2008. http://new.wales.gov.uk/about/departments/dhss/publications/health_pub_index/reports/radiotherapyequipmentneeds%3Flang%3Den.
9. Moller H., Fairley L., Coupland V., et al. The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer 2007, 96:1484-1488.
10. National Cancer Action Team NHS cancer programme for England. Radiotherapy - developing a world class service Available at:, (last accessed 6 January 2010). http://www.cancer.nhs.uk/radiotherapy/.
11. Norlund A. Costs of radiotherapy. Acta Oncol 2003, 42:411-415.
12. Ploquin N.P., Dunscombe P.B. The cost of radiation therapy. Radiother Oncol 2008, 86:217-223.
13. Barton M.B., Gebski V., Manderson C., Langlands A.O. Radiation therapy: are we getting value for money?. Clin Oncol 1995, 7:287-292.
14. Veldeman L., Madani I., Hulstaert F., De Meerleer G., Mareel M., De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008, 9:367-375.
15. Staffurth JN. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol 2010;22:643-657.
16. Mayles P. Survey of the availability and use of advanced radiotherapy technology in the UK. Clin Oncol 2010;22:636-642.
17. Van de Werf E., Lievens Y., Verstraete J., Pauwels K., Van den Bogaert W. Time and motion study of radiotherapy delivery: economic burden of increased quality assurance and IMRT. Radiother Oncol 2009, 93:137-140.
18. Williams M.V., Hoole A.C.F., Dean J.C., et al. Letter to the Editor: IMRT can be faster to deliver than conformal radiotherapy. Radiother Oncol 2010, 95:257-258.
19. Miles E.A., Clark C.H., Urbano M.T., et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 2005, 77:241-246.
20. Pearson S.D., Ladapo J., Prosser L. Intensity modulated radiation therapy (IMRT) for localized prostate cancer Available at:, (last accessed 9 May 2010). http://www.icer-review.org/index.php/imrt.html.
21. Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A. Intensity modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess (in press).
22. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8:475-487.
23. National Collaborating Centre for Cancer Prostate cancer: diagnosis and treatment on behalf of the National Institute for Health and Clinical Excellence, Available at:, (last accessed 9 May 2010). http://guidance.nice.org.uk/CG58/Guidance/pdf/English.
24. Jefferies S., Taylor A., Reznek R. Results of a national survey of radiotherapy planning and delivery in the UK in 2007. Clin Oncol 2009, 21:204-217. and the Radiotherapy Planning Working Party.
25. Clark C.H., Miles E.A., Urbano M.T., et al. UK PARSPORT Trial Management Group collaborators. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br J Radiol 2009, 82:585-594.
26. Sydes M.R., Stephens R.J., Moore A.R., et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol 2004, 72:199-211.
27. Khoo V.S., Dearnaley D.P. Question of dose-fractionation and technique: ingredients for testing hypo fractionation in prostate cancer - the CHHiP trial. Clin Oncol 2008, 20:12-14.
28. Department of Health.Manual for cancer services radiotherapy measures Available at:. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_114759.
29. MacKay R.I., Staffurth J., Poynter A., Routsis D. UK guidelines for the safe delivery of intensity modulated radiotherapy (IMRT). Clin Oncol 2010, 22:707-709.
30. General Medical Council Consent: patients and doctors making decisions together Available at:. http://www.gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp.
31. Maugham TS, et al. Radiotherapy research priorities for the UK. Clin Oncol 2010;22:629-635.